A practical reference on AOD-9604: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-07-14. Anything still debated is marked as such rather than presented as settled.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide fragment | Not a full hormone |
| Molecular target | Proposed adipose tissue lipolysis | Receptor details uncertain |
| Typical research dose | Not established for clinical use | Doses vary across studies |
| Stability in solution | Limited; store cold | Avoid repeated freeze-thaw |
| Regulatory status | Not approved as a drug | Varies by country |
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
On 12 December 1994, the 2nd Battalion (Airborne), 505th Infantry, with the 2nd Platoon of Company C, 307th Engineer Battalion, deployed as part of Operations Safe Haven and Safe Passage. The battalion deployed from Fort Bragg "to restore order" against what American officials termed "Cuban refugees" who had attacked and injured a number of Air Force personnel and one marine while protesting their detainment at Empire Range along the Panama Canal. The battalion participated in the safeguarding of the Cuban refugees, a camp cordon and reorganization, and the active patrolling in and around the refugee camps in and around the Panamanian jungle along the Panama canal for two months. General Engineering support in the area of camp establishment/improvement operations was provided by the Sappers of the habitually associated Task Force Panther Engineer platoon, 2/C-307th. Task Force Panther was commanded by LTC Lloyd J. Austin III, who was later the first African American General to commander of US Central Command and US Secretary of Defense. This support included the planning of camp power requirements, pouring of 78 concrete pads, three-foot bridges, a set of "mock doors" for airborne pre-jump training, and a system of decks for the muddy camp. During the deployment, the paratroopers experienced a 92 °F (33 °C) Christmas Day. They returned to Fort Bragg on 14 February 1995.
== Other metalloenzymes == There are two types of carbon monoxide dehydrogenase: one contains iron and molybdenum, the other contains iron and nickel. Parallels and differences in catalytic strategies have been reviewed. Pb2+ (lead) can replace Ca2+ (calcium) as, for example, with calmodulin or Zn2+ (zinc) as with metallocarboxypeptidases. A new class of Heme oxygenase (HO)-like metalloenzymes class has been identified. Some other metalloenzymes are given in the following table, according to the metal involved.
In December 1966, the UN further iterated that these sanctions were mandatory, and member states were explicitly barred from purchasing Rhodesian export goods, namely tobacco, chromium, copper, asbestos, sugar, and beef. The British government, having already adopted extensive sanctions of its own, dispatched a Royal Navy squadron to monitor oil deliveries in the port of Beira in Mozambique, from which a strategic pipeline ran to Umtali in Rhodesia. The warships were to deter "by force, if necessary, vessels reasonably believed to be carrying oil destined for (Southern) Rhodesia". Some Western nations, such as Switzerland and West Germany, which were not UN member states, continued to conduct business openly with Rhodesia – the latter remained the Smith government's largest trading partner in Western Europe until 1973, when it was admitted to the UN. Japan remained the chief recipient of Rhodesian exports outside the African continent, and Iran also supplied oil to Rhodesia in violation of the embargo. Portugal served as a conduit for Rhodesian goods, which it exported through Mozambique with false certificates of origin. South Africa, too, refused to observe the UN sanctions. In 1971, the Byrd Amendment was passed in the United States, permitting American firms to go on importing Rhodesian chromium and nickel products as normal. Despite the poor showing of sanctions, Rhodesia found it nearly impossible to obtain diplomatic recognition abroad. In 1970, the United States declared it would not recognise UDI "under [any] circumstances".
Sources: en.wikipedia.org
electric sector without an initial drift length followed by a 60° magnetic sector with the same direction of curvature. Sometimes called a "Bainbridge mass spectrometer," this configuration is often used to determine isotopic masses. A beam of positive particles is produced from the isotope under study. The beam is subject to the combined action of perpendicular electric and magnetic fields. Since the forces due to these two fields are equal and opposite when the particles have a velocity given by
In February 2025, Good me held its initial public offering becoming a listed company on the Hong Kong Stock Exchange with the offering raising US$233 million. On its trading debut, its shares dropped 6.4%. The IPO elevated founder Wang Yun'an's personal stake to an estimated HK$8.6 billion (about US$1.2 billion).
Many Indian species have descended from those of Gondwana, the southern supercontinent from which India separated more than 100 million years ago. India's subsequent collision with Eurasia set off a mass exchange of species. However, volcanism and climatic changes later caused the extinction of many endemic Indian forms. Still later, mammals entered India from Asia through two zoogeographic passes flanking the Himalayas. This lowered endemism among India's mammals, which stands at 12.6%, contrasting with 45.8% among reptiles and 55.8% among amphibians. Among endemics are the vulnerable hooded leaf monkey and the threatened Beddome's toad of the Western Ghats. According to the IUCN Red List, India contains 1,021 threatened animal species—99 mammal, 82 bird, 105 reptile, 139 amphibian, 332 fish, 10 mollusk, and 254 other invertebrate—727 threatened plant species, and 4 threatened fungi species. Among them are the endangered Bengal tiger and the Ganges river dolphin. Critically endangered species include the gharial, a crocodilian; the great Indian bustard; and the Indian white-rumped vulture, which has become nearly extinct by having ingested the carrion of diclofenac-treated cattle. Before they were extensively used for agriculture and cleared for human settlement, the thorn forests of Punjab were mingled at intervals with open grasslands that were grazed by large herds of blackbuck preyed on by the Asiatic cheetah; the blackbuck, no longer extant in Punjab, is now severely endangered in India, and the cheetah is extinct.
Sources: en.wikipedia.org
It is proposed to promote lipolysis in fat tissue, the breakdown of stored fat into fatty acids and glycerol. The detailed receptor and signaling mechanisms are not fully established.
Because it is a fragment rather than full growth hormone, it is generally described as lacking growth-promoting effects. Some studies suggest it may influence fat metabolism without the same systemic growth effects, though evidence is limited.
Human trials have measured body weight, fat mass, lean mass, lipid levels, and adverse events. Most have been small or short-term, so conclusions about long-term outcomes are limited.
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.